FDA Inspection
Cayman Pharma s.r.o.Cayman Pharma s.r.o. – FDA Inspection, Jan 30, 2020
Record Details
This FDA Inspection record concerns Cayman Pharma s.r.o., with an inspection on January 30, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Cayman Pharma s.r.o.
- Inspection Date
- January 30, 2020
- Product Type
- Drugs
View Company Profile
ID · 30d542f5-0ae2-4fcb-8c39-5e4de0aaea08
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1132387
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Cayman Pharma s.r.o.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 28, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2017 | Not classified | Office of Inspections and Investigations | |
| March 27, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cayman Pharma s.r.o.
- FDA Inspection 1271067 - 2022-07-28
- FDA Inspection 1011579 - 2017-03-30
- FDA Inspection 876913 - 2014-03-27
- FDA Inspection 722239 - 2011-03-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.